0000939767-20-000128.txt : 20200910
0000939767-20-000128.hdr.sgml : 20200910
20200910203936
ACCESSION NUMBER: 0000939767-20-000128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200908
FILED AS OF DATE: 20200910
DATE AS OF CHANGE: 20200910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hessekiel Jeffrey
CENTRAL INDEX KEY: 0001599803
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 201169730
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_159978475973402.xml
FORM 4
X0306
4
2020-09-08
0
0000939767
EXELIXIS, INC.
EXEL
0001599803
Hessekiel Jeffrey
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
EVP and General Counsel
Common Stock
2020-09-08
4
M
0
59692
1.90
A
313692
D
Common Stock
2020-09-08
4
M
0
190000
6.21
A
503692
D
Common Stock
2020-09-08
4
F
0
160666
20.71
D
343026
D
Common Stock
999
I
By 401(k)
Option (right to buy)
1.9
2020-09-08
4
M
0
59692
0
D
2015-07-20
2022-02-04
Common Stock
59692.0
20000
D
Option (right to buy)
6.21
2020-09-08
4
M
0
190000
0
D
2016-09-16
2022-09-15
Common Stock
190000.0
0
D
Includes 39,058 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents a "net exercise" of outstanding stock options. The Reporting Person received 89,026 shares of Common Stock on the net exercise of stock options to purchase 249,692 shares of Common Stock. The Issuer withheld 160,666 shares of Common Stock underlying the stock options for payment of the exercise prices and tax withholdings using a stock price on September 8, 2020 of $20.71.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 8, 2020.
The option, representing the right to purchase a total of 200,000 shares of Common Stock, became fully exercisable on April 28, 2016.
The option, representing the right to purchase a total of 190,000 shares of Common Stock, became fully exercisable on September 16, 2019.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-09-10